New partnership aims to improve treatment of NCDs in humanitarian settings
WDF has received a grant of DKK 57.5 million from the Novo Nordisk Foundation to advance a nationwide response to the high burden of NCDs among Syrian refugees and vulnerable Lebanese host communities.
